SciELO - Scientific Electronic Library Online

 
vol.81 issue3Long-term outcomes with Boston type 1 keratoprosthesis in ocular burns author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

Share


Arquivos Brasileiros de Oftalmologia

Print version ISSN 0004-2749On-line version ISSN 1678-2925

Abstract

SANCHO, Karlos Frederico Castelo Branco et al. Effects of oral propranolol for circumscribed choroidal hemangioma. Arq. Bras. Oftalmol. [online]. 2018, vol.81, n.3, pp.171-176. ISSN 0004-2749.  http://dx.doi.org/10.5935/0004-2749.20180037.

Purpose:

We aimed to evaluate the effects of oral propranolol for circumscribed choroidal hemangioma.

Methods:

In this prospective, longitudinal interventional study, we administered oral propranolol at a dosage of 1.5 mg/kg/day to five patients with circumscribed choroidal hemangioma. We then evaluated visual acuity, binocular indirect ophthalmoscopy, optical coherence tomography, optical coherence tomography angiography, fluorescein and indocyanine green angiography, and ocular ultrasonography at regular intervals and compared changes from the baseline assessments.

Results:

No clinical or diagnostic changes were observed in the sizes of the circumscribed choroidal hemangiomas during treatment. Complications due to the hemangioma were reduced in the first four months of treatment, followed by maintenance, before worsening in the subsequent three months.

Conclusions:

The study showed that oral propranolol at a dose of 1.5 mg/kg/day did not offer effective monotherapy in the treatment of circumscribed choroidal hemangioma.

Keywords : Hemangioma; Choroid neoplasms; Propranolol; In docyanine green; Tomography, optical coherence.

        · abstract in Portuguese     · text in English     · English ( pdf )